Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Drug Discovery Today (2021) 26(8):19912002
"It makes it look like the FDA-approved drug is still in shortage, when in fact pharmacies are making a business decision: 'We're not going to carry this,'" Brunner said
This indicates that researchers may stop administering this peptide for at least one month following the end of the trial without affecting the IGF-I levels of the test subjects
In the prescribing information, the tablet dosing schedule steps up from 1.5 mg 4 mg 9 mg 25 mg over time to help tolerability
Using peptides supplied in vials also provides a degree of flexibility for research methods, allowing dosages to be altered depending on the effects subjects experience
